289 related articles for article (PubMed ID: 28103579)
1. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
Oncotarget; 2017 Jun; 8(23):37845-37854. PubMed ID: 28103579
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
4. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Effects of Clinicopathological Features on Rectal Cancer Patients undergoing Neoadjuvant Chemoradiotherapy.
Arslan A; Akay E; Turk G; Eren SK
J Coll Physicians Surg Pak; 2021 Apr; 31(4):422-428. PubMed ID: 33866728
[TBL] [Abstract][Full Text] [Related]
6. T-stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics.
Hayes IP; Milanzi E; Pelly RM; Gibbs P; Reece JC
J Surg Oncol; 2022 Sep; 126(4):728-739. PubMed ID: 35635190
[TBL] [Abstract][Full Text] [Related]
7. The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0.
Cui Y; Liu X; Li S; Wang H; Xiang Y; Zhang Y; Song M; Geng J; Liu Z; Teng H; Zhu X; Cai Y; Li Y; Wang W
Clin Transl Oncol; 2024 Apr; 26(4):1012-1021. PubMed ID: 38051436
[TBL] [Abstract][Full Text] [Related]
8. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
10. Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.
Sun Y; Wu X; Lin H; Lu X; Huang Y; Chi P
J Gastrointest Surg; 2021 Apr; 25(4):1019-1028. PubMed ID: 32219686
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of the Neoadjuvant Rectal Score as Compared With the Tumor Regression Grade and Yield Pathologic TNM Stage in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Baek JH; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kim JG
In Vivo; 2020; 34(4):1993-1999. PubMed ID: 32606172
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoradiation therapy using concurrent S-1 and irinotecan in rectal cancer: impact on long-term clinical outcomes and prognostic factors.
Nakamura T; Yamashita K; Sato T; Ema A; Naito M; Watanabe M
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):547-55. PubMed ID: 24929164
[TBL] [Abstract][Full Text] [Related]
13. MRI-detected tumor deposits in cT3 and cT4 rectal cancer following neoadjuvant chemoradiotherapy.
Que YT; Chen Y; Yang XY; Ma YR; Liu YY; Wen ZQ; Lu BL; Wu XH; Zhang ZW; Wu YZ; Yu SP; Yuan JP
Eur Radiol; 2024 May; 34(5):2963-2973. PubMed ID: 37840101
[TBL] [Abstract][Full Text] [Related]
14. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathological and prognostic features of young onset patients with middle-low rectal cancer received neoadjuvant chemoradiotherapy].
Zhang QQ; Wu YL; Li DD; Shen SH; Fang H; Zhu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):574-580. PubMed ID: 34034478
[No Abstract] [Full Text] [Related]
16. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
Sun Y; Zhang Y; Wu X; Lin H; Lu X; Huang Y; Xu Z; Huang S; Wang X; Chi P
J Surg Oncol; 2018 Mar; 117(4):737-744. PubMed ID: 29228455
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.
Sun Y; Zhang Y; Huang Z; Chi P
J Gastrointest Surg; 2019 May; 23(5):1006-1014. PubMed ID: 30187336
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
